Back to search
Scleroderma, Localized
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Scleroderma, Localized trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Scleroderma, Localized trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The Morphea in Adults and Children (MAC) cohort is the first registry for both children and adults with morphea (also known as localized scleroderma) in the cou…
This study aims to investigate the effectiveness of BETY, an exercise approach based on the biopsychosocial model, in children and adults diagnosed with sclerod…
Physical functionality and performance are important for individuals diagnosed with scleroderma. There is a need to address children and adults diagnosed with s…
It is recommended to focus on the physical functionality, chewing, and swallowing performance of individuals diagnosed with scleroderma. There is a need to addr…
Despite a number of prospective studies already initiated in the past years, the current epidemiology and course of interstitial lung disease (ILD) and pulmonar…
In vitro studies have shown that imatinib 1mM inhibits strongly the growth of cutaneous fibroblasts. The hypothesis is that imatinib inhibits PDGFR which is kno…
Localized scleroderma (LS) is a skin disease that can cause complications such as disfigurement and limitation of mobility. Treatment for LS should be initiated…